Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIQ-AI Share News (IQAI)

  • There is currently no data for IQAI

IN BRIEF: IQ-AI amends distribution deal with Blackford Analysis

Mon, 03rd Feb 2025 19:22

IQ-AI Ltd - London-based medical services company - Amends existing distribution agreement with artificial intelligence platform provider Blackford Analysis Ltd. The amendment adds IB Nimble, IB ASL, IB FTB, and IB FTB Express to the agreement, allowing Blackford to also sell these products to their global client base. Acquired by Bayer in early 2023, Blackford operates in the healthcare AI platform and solutions sphere.

Current stock price: 1.66 pence

12-month change: down 42%

By Jeremy Cutler, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2025 Alliance News Ltd. All Rights Reserved.

Related News

IN BRIEF: IQ-AI applies for breakthrough therapy designation for GaM
2 May 2025

IN BRIEF: IQ-AI applies for breakthrough therapy designation for GaM

IQ-AI Ltd - London-based medical services company - Says subsidiary Imaging Biometrics LLC has applied for breakthrough therapy designation from the U...

IN BRIEF: IQ-AI to take GaM to phase II study, flags AI capabilities
22 Jan 2025

IN BRIEF: IQ-AI to take GaM to phase II study, flags AI capabilities

IQ-AI Ltd - London-based medical services company - Provides operations update focusing on artificial intelligence. Explains radiology leads the way i...

IN BRIEF: Braveheart buys 30% stake in IQ-AI from Braveheart CEO Brown
14 Oct 2024

IN BRIEF: Braveheart buys 30% stake in IQ-AI from Braveheart CEO Brown

IQ-AI Ltd - parent of Wisconsin-based Imaging Biometrics LLC, which provides quantitative imaging platforms and therapeutics for the diagnosis and tre...

IQ-AI News

UK TRADING UPDATE SUMMARY: Airtel And Telkom Abort Kenya Combination
5 Aug 2020

UK TRADING UPDATE SUMMARY: Airtel And Telkom Abort Kenya Combination

UK TRADING UPDATE SUMMARY: Airtel And Telkom Abort Kenya Combination

IN BRIEF: IQ-AI Says Development Of Stroke Diagnostic Product On Track
27 Jul 2020

IN BRIEF: IQ-AI Says Development Of Stroke Diagnostic Product On Track

IN BRIEF: IQ-AI Says Development Of Stroke Diagnostic Product On Track

IN BRIEF: IQ-AI Starts Development Of Cancer Detection Product
10 Jul 2020

IN BRIEF: IQ-AI Starts Development Of Cancer Detection Product

IN BRIEF: IQ-AI Starts Development Of Cancer Detection Product

UK Shareholder Meetings Calendar - Next 7 Days
8 Jun 2020

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

UK TRADING UPDATE SUMMARY: Feedback And Tissue Regenix Secure CE Marks
1 Jun 2020

UK TRADING UPDATE SUMMARY: Feedback And Tissue Regenix Secure CE Marks

UK TRADING UPDATE SUMMARY: Feedback And Tissue Regenix Secure CE Marks

IQ-AI Shares Fall As Annual Loss Widens Despite Revenue Growth
4 May 2020

IQ-AI Shares Fall As Annual Loss Widens Despite Revenue Growth

IQ-AI Shares Fall As Annual Loss Widens Despite Revenue Growth

IQ-AI Secures StoneChecker Software Approval In South Korea
20 Jan 2020

IQ-AI Secures StoneChecker Software Approval In South Korea

IQ-AI Secures StoneChecker Software Approval In South Korea

IQ-AI Signs Distribution Agreement For Liver Analysis Technology
9 Jan 2020

IQ-AI Signs Distribution Agreement For Liver Analysis Technology

IQ-AI Signs Distribution Agreement For Liver Analysis Technology